InnerScope Partners with Ainnova Tech in OTCHealth Acquisition
InnerScope Hearing Technologies announced its participation in the acquisition of OTCHealth Inc. by Ainnova Tech, Inc., according to a press release. The partnership allows InnerScope to leverage its retail distribution network and technology portfolio to enhance access to preventive hearing and health solutions.
As an equity owner in OTCHealth, InnerScope will transfer most of its sales operations, including retail agreements with major U.S. outlets such as Walmart, CVS, Target, and Walgreens, to OTCHealth. The move will enable OTCHealth, now a subsidiary of Ainnova, to expand its reach across more than 15,000 independent pharmacies and healthcare providers nationwide.
Under the agreement, InnerScope will hold equity and profit participation in both OTCHealth and Ainnova following the acquisition. The company will focus on advancing its proprietary hearing technologies, which will be integrated into OTCHealth’s digital health offerings supported by Ainnova’s AI-driven diagnostics platform.
The collaboration aims to combine InnerScope’s hearing care expertise, OTCHealth’s digital health infrastructure, and Ainnova’s AI-based analytics to improve early detection of conditions linked to hearing loss, such as diabetes and cognitive decline.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
HealthpointCapital Invests in Surgical Software Company Ospitek
Assort Health and Nextech to Build AI Agent for Ophthalmology Practices
ELEHEAR Wins Two 2026 Hearing Technology Awards
I-care Acquires Amiral Technologies for Predictive Maintenance AI
OuterSignal Raises $22M Series A for Customer Personalization Platform
Daily AI Brief: the AI news that matters, in your inbox.